AngioDynamics
ANGO
$7.02
Share price
-1.27%
Change (1 day)
-70.20%
Change (1 year)
Categories
Revenue for AngioDynamics (ANGO)
Revenue in 2023 (TTM): $0.33 B
According to AngioDynamics's latest financial reports the company's current revenue (TTM) is $0.33 B. In 2022 the company made a revenue of $0.32 B an increase over the years 2021 revenue that were of $0.30 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for AngioDynamics from 2004 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.33 B | 3.3% |
| 2022 | $0.32 B | 8.13% |
| 2021 | $0.30 B | 11.87% |
| 2020 | $0.27 B | -14.93% |
| 2019 | $0.31 B | -8.69% |
| 2018 | $0.34 B | 1.27% |
| 2017 | $0.34 B | -3.7% |
| 2016 | $0.35 B | 2.13% |
| 2015 | $0.35 B | -3.13% |
| 2014 | $0.36 B | 5.22% |
| 2013 | $0.34 B | 22.93% |
| 2012 | $0.27 B | 25.07% |
| 2011 | $0.22 B | 2.87% |
| 2010 | $0.21 B | 5.61% |
| 2009 | $0.20 B | 14.18% |
| 2008 | $0.18 B | 22.95% |
| 2007 | $0.14 B | 66.59% |
| 2006 | $88.01 M | 29.7% |
| 2005 | $67.85 M | 27.38% |
| 2004 | $53.27 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $93.76 B | 27,578.66% | 🇺🇸 USA |
 Boston Scientific BSX | $13.40 B | 3,855.70% | 🇺🇸 USA |
 Teleflex TFX | $2.89 B | 755.78% | 🇺🇸 USA |
 Merit Medical MMSI | $1.19 B | 253.71% | 🇺🇸 USA |
 LeMaitre Vascular LMAT | $0.17 B | -47.70% | 🇺🇸 USA |
 ICU Medical
ICUI | $2.29 B | 577.14% | 🇺🇸 USA |